PFM Health Sciences, LP 13F holdings, Q4 2025
Holdings as of December 31, 2025 · filings on SEC EDGAR · latest filing →
PFM Health Sciences, LP disclosed 77 US equity positions worth $987.7m in its Q4 2025 13F filing. The largest position was THC at 8.0% of the reported book, followed by LLY and AXSM. Against the Q3 2025 filing, it opened 15 new positions, added to 12 and reduced 23 among the top 50 holdings.
What did PFM Health Sciences, LP own in Q4 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2025 |
|---|---|---|---|---|---|---|---|
| 1 | THC TENET HEALTHCARE CORP | Healthcare | 8.0% | $79.0m | 397,767 | -14% | reduced |
| 2 | LLY ELI LILLY & CO | Healthcare | 7.4% | $73.4m | 68,289 | -70% | reduced |
| 3 | AXSM AXSOME THERAPEUTICS INC | Healthcare | 4.7% | $45.9m | 251,562 | -53% | reduced |
| 4 | PEN PENUMBRA INC | Healthcare | 4.6% | $45.1m | 145,171 | -26% | reduced |
| 5 | ASND ASCENDIS PHARMA A/S | Healthcare | 3.8% | $37.9m | 177,685 | 22% | added |
| 6 | UTHR UNITED THERAPEUTICS CORP DEL | Healthcare | 3.3% | $33.0m | 67,743 | -29% | reduced |
| 7 | CNC CENTENE CORP DEL | Healthcare | 3.0% | $29.9m | 725,424 | 26% | added |
| 8 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 2.4% | $23.4m | 306,506 | -6% | reduced |
| 9 | ADMA ADMA BIOLOGICS INC | Healthcare | 2.3% | $23.2m | 1,270,894 | 8% | added |
| 10 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 2.3% | $23.1m | 163,197 | 185% | added |
| 11 | GKOS GLAUKOS CORP | Healthcare | 2.3% | $22.8m | 201,676 | – | new |
| 12 | TMO THERMO FISHER SCIENTIFIC INC | Healthcare | 2.2% | $22.0m | 37,915 | 1539% | added |
| 13 | EW EDWARDS LIFESCIENCES CORP | Healthcare | 2.1% | $21.0m | 246,835 | -35% | reduced |
| 14 | ICLR ICON PLC | Healthcare | 2.1% | $21.0m | 115,336 | -14% | reduced |
| 15 | INBX INHIBRX BIOSCIENCES INC | 2.1% | $21.0m | 265,517 | 11% | added | |
| 16 | MDT MEDTRONIC PLC | Healthcare | 2.1% | $20.5m | 213,796 | – | new |
| 17 | NEO NEOGENOMICS INC | Healthcare | 2.0% | $19.9m | 1,694,051 | -23% | reduced |
| 18 | MRK MERCK & CO INC | Healthcare | 2.0% | $19.8m | 187,834 | -21% | reduced |
| 19 | AMRX AMNEAL PHARMACEUTICALS INC | Healthcare | 1.9% | $18.5m | 1,465,480 | 312% | added |
| 20 | SYK STRYKER CORPORATION | Healthcare | 1.8% | $17.9m | 50,852 | – | new |
| 21 | UNH UNITEDHEALTH GROUP INC | Healthcare | 1.7% | $16.7m | 50,539 | – | new |
| 22 | WAT WATERS CORP | Healthcare | 1.7% | $16.4m | 43,208 | 41% | added |
| 23 | ASND ASCENDIS PHARMA A/S | 1.5% | $15.1m | 10,655,000 | -7% | reduced | |
| 24 | DXCM DEXCOM INC | Healthcare | 1.5% | $15.1m | 227,357 | – | new |
| 25 | CNTA CENTESSA PHARMACEUTICALS PLC | 1.5% | $14.8m | 591,601 | -11% | reduced | |
| 26 | INDIVIOR PLC | 1.3% | $12.9m | 360,695 | -36% | reduced | |
| 27 | CAH CARDINAL HEALTH INC | Healthcare | 1.3% | $12.8m | 62,341 | – | new |
| 28 | UHS UNIVERSAL HLTH SVCS INC | Healthcare | 1.3% | $12.5m | 57,409 | -51% | reduced |
| 29 | TFX TELEFLEX INCORPORATED | Healthcare | 1.3% | $12.5m | 102,395 | – | new |
| 30 | RVMD REVOLUTION MEDICINES INC | Healthcare | 1.2% | $12.1m | 151,453 | -54% | reduced |
| 31 | SLNOEUR SOLENO THERAPEUTICS INC | 1.2% | $11.5m | 247,893 | 2% | added | |
| 32 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 0.9% | $9.2m | 31,163 | -49% | reduced |
| 33 | ISRG INTUITIVE SURGICAL INC | Healthcare | 0.9% | $8.7m | 15,410 | -80% | reduced |
| 34 | GILD GILEAD SCIENCES INC | Healthcare | 0.9% | $8.7m | 71,018 | – | new |
| 35 | JAZZ JAZZ PHARMACEUTICALS PLC | Healthcare | 0.9% | $8.6m | 50,511 | – | new |
| 36 | CVS CVS HEALTH CORP | Healthcare | 0.9% | $8.6m | 107,767 | -69% | reduced |
| 37 | SNY SANOFI SA | 0.9% | $8.5m | 176,413 | – | new | |
| 38 | IQV IQVIA HLDGS INC | Healthcare | 0.9% | $8.5m | 37,852 | – | new |
| 39 | ITGR INTEGER HLDGS CORP | Healthcare | 0.8% | $8.4m | 106,585 | – | new |
| 40 | COO COOPER COS INC | Healthcare | 0.8% | $8.3m | 100,802 | 36% | added |
| 41 | VEEV VEEVA SYS INC | Healthcare | 0.7% | $7.3m | 32,489 | -22% | reduced |
| 42 | OSCR OSCAR HEALTH INC | Healthcare | 0.7% | $7.2m | 499,837 | -39% | reduced |
| 43 | BLLN BILLIONTOONE INC | 0.7% | $7.2m | 87,547 | – | new | |
| 44 | CGON CG ONCOLOGY INC | Healthcare | 0.7% | $6.8m | 163,967 | 4% | added |
| 45 | VKTX VIKING THERAPEUTICS INC | Healthcare | 0.7% | $6.6m | 188,956 | 3% | added |
| 46 | ALGN ALIGN TECHNOLOGY INC | Healthcare | 0.7% | $6.6m | 42,304 | – | new |
| 47 | HCA HCA HEALTHCARE INC | Healthcare | 0.7% | $6.5m | 13,865 | -79% | reduced |
| 48 | PSNL PERSONALIS INC | Healthcare | 0.6% | $6.4m | 805,817 | – | new |
| 49 | VERA VERA THERAPEUTICS INC | Healthcare | 0.6% | $5.5m | 107,690 | -79% | reduced |
| 50 | CMPS COMPASS PATHWAYS PLC | Healthcare | 0.5% | $5.4m | 779,618 | -53% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.